1,6-Dibromodulcitol is an intermediate in the synthesis of Dulcitol Diepoxide (D720515). Dulcitol Diepoxide is a cytostatic drug. Dulcitol Diepoxide can be used for treatment of leukemia, lung cancer, multiple myeloma, and nasopharyngeal carcinoma.
ChEBI: Mitolactol is an alcohol and an organobromine compound.
White powder. Insoluble in water.
A halogenated alcohol. Flammable and/or toxic gases are generated by the combination of alcohols with alkali metals, nitrides, and strong reducing agents. They react with oxoacids and carboxylic acids to form esters plus water. Oxidizing agents convert them to aldehydes or ketones. Alcohols exhibit both weak acid and weak base behavior. They may initiate the polymerization of isocyanates and epoxides.
ACUTE/CHRONIC HAZARDS: DIBROMODULCITOL is toxic when ingested.
Data is not available for DIBROMODULCITOL, but DIBROMODULCITOL is probably combustible.
Poison by ingestion.
Moderately toxic by intraperitoneal route.
Questionable carcinogen with experimental
carcinogenic, neoplastigenic, and
tumorigenic data. Human mutation data
reported. An anti-cancer agent taken orally.
When heated to decomposition it emits very
toxic fumes of Br-.
